Literature DB >> 6254705

Lymphocyte cyclic AMP levels in primary hypogammaglobulinaemia: lack of correlation with response to phytohaemagglutinin.

A D Webster, M E North, C Newton, G L Asherson.   

Abstract

Normal levels of lymphocyte cyclic AMP were found in fourteen of fifteen patients with primary hypogammaglobulinaemia. One patient with adult-onset hypogammaglobulinaemia had low cyclic AMP levels with a very poor rise after prostaglandin E1 stimulation. Five of the patients had severely depressed thymidine uptake by their phytohaemagglutinin-stimulated lymphocytes but there was no significant difference between their lymphocyte cyclic AMP levels and those of patients with normal lymphocyte responses. Removal of monocytes from concanavalin A-stimulated lymphocyte cultures from three of these patients did not affect the severe depression of leucine uptake. These findings indicate that the depression of lymphocyte response to mitogens seen in some patients with late-onset primary hypogammaglobulinaemia is not due to raised levels of lymphocyte cyclic AMP; and not usually due to prostaglandins released by monocytes in the cultures.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254705      PMCID: PMC1536995     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Purification of human T and B lymphocytes.

Authors:  M F Greaves; G Brown
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

2.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

3.  A simple direct assay for cyclic AMP in plasma and other biological samples using an improved competitive protein binding technique.

Authors:  K C Tovey; K G Oldham; J A Whelan
Journal:  Clin Chim Acta       Date:  1974-11-08       Impact factor: 3.786

4.  Enhanced transformation of human immunocompetent cells by dibutyryl adenosine cyclic 3',5'-monophosphate.

Authors:  R C Gallo; J Whang-Peng
Journal:  J Natl Cancer Inst       Date:  1971-07       Impact factor: 13.506

5.  Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia.

Authors:  T A Waldmann; M Durm; S Broder; M Blackman; R M Blaese; W Strober
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

6.  Antigen stimulation of 3H thymidine incorporation by subpopulations of human peripheral blood cells.

Authors:  S A Eisen; L R Lyle; C W Parker
Journal:  J Immunol       Date:  1973-09       Impact factor: 5.422

7.  Guanosine 3':5'-cyclic monophosphate: a possible intracellular mediator of mitogenic influences in lymphocytes.

Authors:  J W Hadden; E M Hadden; M K Haddox; N D Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

8.  Enhanced effects of prostaglandin E1 and dibutyryl cyclic AMP upon human lymphocytes in the presence of cortisol.

Authors:  J Mendelsohn; M M Multer; R F Boone
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

9.  Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins.

Authors:  D V Kimberg; M Field; J Johnson; A Henderson; E Gershon
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

10.  Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin.

Authors:  J W Smith; A L Steiner; C W Parker
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

View more
  2 in total

1.  LDH isoenzymes in the T lymphocytes of patients with primary hypogammaglobulinaemia.

Authors:  N Matamoros; E Abad; A D Webster
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

2.  Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.

Authors:  A D Webster; H Ip; S Pereira
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.